全文获取类型
收费全文 | 134206篇 |
免费 | 3795篇 |
国内免费 | 1篇 |
专业分类
财政金融 | 25587篇 |
工业经济 | 11217篇 |
计划管理 | 21630篇 |
经济学 | 28980篇 |
综合类 | 1449篇 |
运输经济 | 963篇 |
旅游经济 | 2487篇 |
贸易经济 | 22647篇 |
农业经济 | 6074篇 |
经济概况 | 16720篇 |
信息产业经济 | 8篇 |
邮电经济 | 240篇 |
出版年
2021年 | 829篇 |
2020年 | 1627篇 |
2019年 | 2381篇 |
2018年 | 2344篇 |
2017年 | 2499篇 |
2016年 | 2690篇 |
2015年 | 2093篇 |
2014年 | 3400篇 |
2013年 | 15300篇 |
2012年 | 4196篇 |
2011年 | 4141篇 |
2010年 | 3686篇 |
2009年 | 4291篇 |
2008年 | 3865篇 |
2007年 | 3222篇 |
2006年 | 3555篇 |
2005年 | 3527篇 |
2004年 | 3115篇 |
2003年 | 2870篇 |
2002年 | 2845篇 |
2001年 | 2607篇 |
2000年 | 2556篇 |
1999年 | 2446篇 |
1998年 | 2321篇 |
1997年 | 2343篇 |
1996年 | 2183篇 |
1995年 | 2000篇 |
1994年 | 2012篇 |
1993年 | 1980篇 |
1992年 | 2037篇 |
1991年 | 1941篇 |
1990年 | 1759篇 |
1989年 | 1565篇 |
1988年 | 1503篇 |
1987年 | 1518篇 |
1986年 | 1593篇 |
1985年 | 2346篇 |
1984年 | 2233篇 |
1983年 | 2050篇 |
1982年 | 1897篇 |
1981年 | 1874篇 |
1980年 | 1829篇 |
1979年 | 1756篇 |
1978年 | 1588篇 |
1977年 | 1577篇 |
1976年 | 1352篇 |
1975年 | 1237篇 |
1974年 | 1162篇 |
1973年 | 1150篇 |
1972年 | 863篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
71.
The paper investigates whether patent fees are an effective mechanism to deter the filing of low‐quality patent applications. The study analyzes the effect on patent quality of the Patent Law Amendment Act of 1982, which resulted in a substantial increase in patenting fees at the U.S. Patent and Trademark Office. Results from a series of difference‐in‐differences regressions suggest that the increase in fees led to a weeding out of low‐quality patents. About 10% of patents in the lowest quality decile were filtered out, with the effect concentrated in the patents of firms whose overall patent portfolio was medium to large (more than 20 patents). The study has strong policy implications in the current context of concerns about declines in patent quality. 相似文献
72.
Díaz-Fernández M. Carmen González-Rodríguez M. Rosario Pawlak Marek Simonetti Biagio 《Quality and Quantity》2019,53(5):2421-2438
Quality & Quantity - Family firms (FFs) are the backbone of entrepreneurial fabric in many countries. Management of such businesses is complex because of their features: the overlap between... 相似文献
73.
We commemorate the 50th anniversary of Ball and Brown [1968] by chronicling its impact on capital market research in accounting. We trace the evolution of various research paths that post–Ball and Brown [1968] researchers took as they sought to build on the foundation laid by Ball and Brown [1968] to create a body of research on the usefulness, timeliness, and other properties of accounting numbers. We discuss how those paths often link back to the groundwork laid and questions originally posed in Ball and Brown [1968]. 相似文献
74.
Philip S. Wells Anthonie W. A. Lensing Lloyd Haskell Bennett Levitan François Laliberté Michael Durkin 《Journal of medical economics》2018,21(6):587-594
Aims: The EINSTEIN-Extension trial (EINSTEIN-EXT) found that continued treatment with rivaroxaban for an additional 6 or 12 months (vs placebo) after 6–12 months of initial anticoagulation significantly reduced the risk of recurrent venous thromboembolism (VTE) with a small non-significant increased risk of major bleeding (none fatal or in critical site). This study aimed to compare total healthcare cost between rivaroxaban and placebo, based on the EINSTEIN-EXT event rates.Methods: Total healthcare cost was calculated as the sum of treatment and clinical event costs from a US managed care perspective. Treatment duration and event rates were obtained from the EINSTEIN-EXT study. Adjustment on treatment duration was made by assuming a 10% non-adherence rate. Drug costs were based on wholesale acquisition costs. Cost estimates for clinical events (i.e. recurrent deep vein thrombosis [DVT], recurrent pulmonary embolism, major bleeding, clinically relevant non-major bleeding) were determined from the literature. Results were examined over a ±20% range of each cost component and over 95% confidence intervals (CIs) of event rate differences in deterministic (one-way) and probabilistic sensitivity analyses (PSA).Results: Total healthcare cost was $1,454 lower for rivaroxaban-treated (vs placebo-treated) patients in the base-case, with a lower clinical event cost fully offsetting drug cost. The cost savings of recurrent DVT alone (–$3,102) was greater than drug cost ($2,723). Total healthcare cost remained lower for rivaroxaban in the majority (73%) of PSA (cost difference [95% CI]?=?–$1,454 [–$2,396, $1,231]).Limitations: This study was conducted over the 1-year observation period of the EINSTEIN-EXT trial, which limited “real-world” applicability and examination of long-term economic impact. Assumptions on drug and clinical event costs were US-based and, thus, not applicable to other healthcare systems.Conclusions: Total healthcare costs were estimated to be lower for patients continuing rivaroxaban therapy compared to those receiving placebo in VTE patients who had completed 6–12 months of VTE treatment. 相似文献
75.
Rating agencies produce ratings used by investors, but obtain most of their revenue from issuers, leading to a conflict of interest. We employ a unique data set on the use of non-rating services, and the associated payments, in India, to test if this conflict affects ratings quality. Agencies rate issuers that pay them for non-rating services higher (than agencies not hired for such services). Such issuers also have higher default rates. Both effects are increasing in the amount paid. These results suggest that issuers which hire agencies for non-rating services receive higher ratings despite having higher default risk. 相似文献
76.
77.
James L. Chan 《公共资金与管理》2019,39(1):64-69
China’s reform on central–local fiscal reform has slowed down in recent years. The appointment of a new finance minister experienced in local government affairs is expected to renew the reform affirmed by the Chinese Communist Party (CCP) congress in late 2017. China has unprecedentedly identified a comprehensive list of 81 national basic public services as entitlements. Eighteen of them are subject to national and local standards, and co-financed by central and local governments. A new cost-sharing method for 10 of these services classifies sub-national jurisdictions into five tiers, in which the central government’s share declines from 80% to 10%. These measures, effective in 2019, aim at creating a ‘harmonious and moderately prosperous society’. 相似文献
78.
79.
Much has changed in the realms of occupational licensing since BJIR last ran a special issue on the subject in 2010. The number of occupations subject to licensing has been growing, the data available to investigate the incidence and effects of licensing have improved immeasurably, and the policy environment surrounding licensing has changed. This issue reflects these changes with eight papers from North America and Europe covering the incidence of licensing, and its effects on wages, inequality, employment, quality of service provision and rent extraction by the organizations who undertake licensing. 相似文献
80.
Past research has reported that learning processes in early stage R&D are either chaotic, or absent. We challenge this finding by elaborating Van de Ven et al.’s trial‐and‐error learning model and explore an alternative conceptualization. We explored the combinations of positive and negative outcomes and action course continuation and modification. We use data gathered in an R&D setting of a 4‐years pre‐competitive knowledge generation project in the Dutch paper and board industry. Whereas the Van de Ven and Polley (1992) approach applied on our data also would lead us to conclude that ‘no learning’ would happen, our decomposed model identified three distinct learning patterns: (1) a virtuous pattern of positive outcomes resulting in continuations of action courses; (2) a vacuous pattern of negative outcomes resulting in modifications of action courses; and (3) a verification pattern of positive outcomes resulting in modifications of action courses. We observed the virtuous and verification patterns during the first 2 years and virtuous and vacuous learning in the second 2 years. These results might be useful for R&D managers since they provide insight into how an early stage R&D project can develop and where managers might intervene and adjust action courses. 相似文献